Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Immunodominance in CD4 T-cell responses: implications for immune responses to influenza virus and for vaccine design.

Sant AJ, Chaves FA, Krafcik FR, Lazarski CA, Menges P, Richards K, Weaver JM.

Expert Rev Vaccines. 2007 Jun;6(3):357-68. Review.

PMID:
17542751
2.
3.

Helper T cell-regulated B cell immunity.

McHeyzer-Williams LJ, Malherbe LP, McHeyzer-Williams MG.

Curr Top Microbiol Immunol. 2006;311:59-83. Review.

PMID:
17048705
4.

Identification of novel HLA-DR1-restricted epitopes from the hepatitis B virus envelope protein in mice expressing HLA-DR1 and vaccinated human subjects.

Pajot A, Michel ML, Mancini-Bourgine M, Ungeheuer MN, Ojcius DM, Deng Q, Lemonnier FA, Lone YC.

Microbes Infect. 2006 Oct;8(12-13):2783-90. Epub 2006 Sep 12.

PMID:
17045504
5.

Emerging respiratory viruses: challenges and vaccine strategies.

Gillim-Ross L, Subbarao K.

Clin Microbiol Rev. 2006 Oct;19(4):614-36. Review.

6.

CD4+ T-cell memory: generation and multi-faceted roles for CD4+ T cells in protective immunity to influenza.

Swain SL, Agrewala JN, Brown DM, Jelley-Gibbs DM, Golech S, Huston G, Jones SC, Kamperschroer C, Lee WH, McKinstry KK, Román E, Strutt T, Weng NP.

Immunol Rev. 2006 Jun;211:8-22. Review. Erratum in: Immunol Rev. 2006 Oct;213:256.

7.

Epigenetic remodeling of the IL-2 and IFN-gamma loci in memory CD8 T cells is influenced by CD4 T cells.

Northrop JK, Thomas RM, Wells AD, Shen H.

J Immunol. 2006 Jul 15;177(2):1062-9.

8.

Host range restriction and pathogenicity in the context of influenza pandemic.

Neumann G, Kawaoka Y.

Emerg Infect Dis. 2006 Jun;12(6):881-6. Review.

9.

New WHO influenza vaccine recommendations for 2005-2006 season, northern hemisphere.

World Health Organization..

Euro Surveill. 2005 Feb 17;10(2):E050217.1. No abstract available.

PMID:
16685098
10.
11.

Predicting population coverage of T-cell epitope-based diagnostics and vaccines.

Bui HH, Sidney J, Dinh K, Southwood S, Newman MJ, Sette A.

BMC Bioinformatics. 2006 Mar 17;7:153.

12.

Peptide binding motif predictive algorithms correspond with experimental binding of leukemia vaccine candidate peptides to HLA-A*0201 molecules.

Gomez-Nunez M, Pinilla-Ibarz J, Dao T, May RJ, Pao M, Jaggi JS, Scheinberg DA.

Leuk Res. 2006 Oct;30(10):1293-8. Epub 2006 Mar 14.

PMID:
16533527
13.

Vaccines for pandemic influenza.

Luke CJ, Subbarao K.

Emerg Infect Dis. 2006 Jan;12(1):66-72. Review.

14.

Cell-mediated protection in influenza infection.

Thomas PG, Keating R, Hulse-Post DJ, Doherty PC.

Emerg Infect Dis. 2006 Jan;12(1):48-54. Review.

15.

Peptide-binding assays and HLA II transgenic Abeta degrees mice are consistent and complementary tools for identifying HLA II-restricted peptides.

Depil S, Angyalosi G, Moralès O, Delacre M, Delhem N, François V, Georges B, Hammer J, Maillère B, Auriault C, Pancré V.

Vaccine. 2006 Mar 20;24(13):2225-9. Epub 2005 Dec 9.

PMID:
16469420
16.

Development of effective vaccines against pandemic influenza.

Subbarao K, Murphy BR, Fauci AS.

Immunity. 2006 Jan;24(1):5-9.

17.

Avian flu to human influenza.

Lewis DB.

Annu Rev Med. 2006;57:139-54. Review.

PMID:
16409141
19.

Emerging influenza viruses: past and present.

Kobasa D, Kawaoka Y.

Curr Mol Med. 2005 Dec;5(8):791-803. Review.

PMID:
16375713
20.

The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes.

Sant AJ, Chaves FA, Jenks SA, Richards KA, Menges P, Weaver JM, Lazarski CA.

Immunol Rev. 2005 Oct;207:261-78. Review.

PMID:
16181342

Supplemental Content

Support Center